We are live on
!
Find out more
CPRC
Consolidated Portfolio Review Corp Portfolio holdings
AUM
$1.2B
1-Year Est. Return
13.59%
This Fund
S&P 500
This Quarter
Est. Return
+8.18%
1 Year Est. Return
+13.59%
3 Year Est. Return
+65.38%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$723M
AUM Growth
+$98.6M
(+16%)
Cap. Flow
+$55M
Cap. Flow
% of AUM
7.61%
Top 10 Holdings %
Top 10 Hldgs %
24.76%
Holding
461
New
83
Increased
229
Reduced
118
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.92M |
| 2 |
Goldman Sachs MarketBeta US Equity ETF
GSUS
|
+$1.84M |
| 3 |
Invesco S&P 500 Revenue ETF
RWL
|
+$1.78M |
| 4 |
PIMCO Corporate & Income Opportunity Fund
PTY
|
+$1.76M |
| 5 |
BlackRock Income Trust
BKT
|
+$1.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$2.3M |
| 2 |
Spotify
SPOT
|
+$2.01M |
| 3 |
SDHY
PGIM Short Duration High Yield Opportunities Fund
SDHY
|
+$1.88M |
| 4 |
Nuveen Real Asset Income & Growth Fund
JRI
|
+$1.37M |
| 5 |
PIMCO Dynamic Income Fund
PDI
|
+$1.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.98% |
| 2 | Financials | 3.06% |
| 3 | Healthcare | 2.9% |
| 4 | Communication Services | 2.4% |
| 5 | Real Estate | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
iShares Genomics Immunology and Healthcare ETF
IDNA
$209M
| – | – |
-12,693
| Closed | -$260K |
|
|
452
Nuveen Real Asset Income & Growth Fund
JRI
$349M
| – | – |
-106,198
| Closed | -$1.37M |
|
453
ALPS O'Shares Global Internet Giants ETF
OGIG
$111M
| – | – |
-9,281
| Closed | -$405K |
|
454
Virtus InfraCap US Preferred Stock ETF
PFFA
$2.51B
| – | – |
-53,676
| Closed | -$1.14M |
|
455
ProShares Short S&P500
SH
$844M
| – | – |
-8,865
| Closed | -$395K |
|
456
Snowflake
SNOW
$115B
| – | – |
-1,380
| Closed | -$202K |
|
|
457
Spotify
SPOT
$101B
| – | – |
-3,654
| Closed | -$2.01M |
|
458
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.5B
| – | – |
-4,978
| Closed | -$203K |
|
459
T-Mobile US
TMUS
$190B
| – | – |
-863
| Closed | -$230K |
|
460
UnitedHealth
UNH
$364B
| – | – |
-636
| Closed | -$333K |
|
461
Vanguard Energy ETF
VDE
$10.4B
| – | – |
-1,633
| Closed | -$212K |
|
Similar funds
AIM
VC
SC
SCM
MMFA
EC
NPIC
CCS
Consolidated Portfolio Review Corp's Q2 2025 Portfolio in Review
As of Q2 2025, Consolidated Portfolio Review Corp held 461 positions worth $723M, up 16% from $624M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Consolidated Portfolio Review Corp deployed $55M of net new capital in Q2 2025, opening 83 new positions and adding to 229 existing holdings. Its largest new stake was Goldman Sachs MarketBeta US Equity ETF: 23,309 shares worth $1.99M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Netflix, an estimated $2.3M trimmed.
- Consolidated Portfolio Review Corp's largest Q2 2025 buy was Goldman Sachs MarketBeta US Equity ETF: 23,309 shares worth $1.99M.
- Consolidated Portfolio Review Corp added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $2.92M increase.
- Consolidated Portfolio Review Corp's biggest Q2 2025 reduction was Netflix, cutting an estimated $2.3M.
- Consolidated Portfolio Review Corp fully exited Spotify in Q2 2025, selling an estimated $2.01M.
- Consolidated Portfolio Review Corp's ten largest holdings make up 25% of its $723M portfolio in Q2 2025.
- Consolidated Portfolio Review Corp opened 83 new positions and closed 16 in Q2 2025.
- Consolidated Portfolio Review Corp's portfolio value rose 16% quarter-over-quarter to $723M.
Based on Consolidated Portfolio Review Corp's 13F filing for Q2 2025, filed 18 Jul 2025.